AGILE THERAPEUTICS INC AGRX
COM · Common Stock · CUSIP 00847L100
0
institutional holders
-40 vs Q1 2022
—reported value*
0 new
0 added
0 reduced
40 sold out
net sold ≈ $182.5m (-40.6m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 50 |
| Q1 2020 | 68 |
| Q2 2020 | 81 |
| Q3 2020 | 81 |
| Q4 2020 | 81 |
| Q1 2021 | 79 |
| Q2 2021 | 72 |
| Q3 2021 | 55 |
| Q4 2021 | 48 |
| Q1 2022 | 40 |
| Q2 2022 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 32 | 43 |
| Q4 2020 | 37 | 26 |
| Q1 2021 | 31 | 42 |
| Q2 2021 | 36 | 50 |
| Q3 2021 | 13 | 42 |
| Q4 2021 | 21 | 29 |
| Q1 2022 | 17 | 20 |
| Q2 2022 | 0 | 40 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2021 | $363.0k | $48.0k | 0.13 |
| Q4 2021 | $249.0k | $0 | 0.00 |
| Q1 2022 | $50.0k | $0 | 0.00 |
| Q2 2022 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| PERCEPTIVE ADVISORS LLC | Sold out | -21.3m |
| ARMISTICE CAPITAL, LLC | Sold out | -4.5m |
| VANGUARD GROUP INC | Sold out | -3.9m |
| INVESTOR AB | Sold out | -3.5m |
| D. E. Shaw & Co., Inc. | Sold out | -2.2m |
| BlackRock Inc. | Sold out | -1.5m |
| MILLENNIUM MANAGEMENT LLC | Sold out | -841.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -757.9k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -621.2k |
| STATE STREET CORP | Sold out | -290.3k |
Holders, Q2 2022
| Manager | Shares | Change |
|---|